| Analysis | Metabolite Name | Measured Value | Units | Model | Intervention |
|---|---|---|---|---|---|
| Normal phase UNSPECIFIED ION MODE | Creatine | 0.23 | peak area | Wild type | B. breve MCC1274 |
| Normal phase UNSPECIFIED ION MODE | Creatine | 0.24 | peak area | Wild type | Saline |
| Normal phase UNSPECIFIED ION MODE | Creatine | 0.27 | peak area | Wild type | B. breve MCC1274 |
| Normal phase UNSPECIFIED ION MODE | Creatine | 0.30 | peak area | Wild type | Saline |
| Normal phase UNSPECIFIED ION MODE | Creatine | 0.32 | peak area | Wild type | Saline |
| Normal phase UNSPECIFIED ION MODE | Creatine | 0.33 | peak area | Alzheimer’s disease model | Saline |
| Normal phase UNSPECIFIED ION MODE | Creatine | 0.35 | peak area | Alzheimer’s disease model | Saline |
| Normal phase UNSPECIFIED ION MODE | Creatine | 0.36 | peak area | Alzheimer’s disease model | B. breve MCC1274 |
| Normal phase UNSPECIFIED ION MODE | Creatine | 0.39 | peak area | Alzheimer’s disease model | B. breve MCC1274 |
| Normal phase UNSPECIFIED ION MODE | Creatine | 0.40 | peak area | Alzheimer’s disease model | Saline |
| Normal phase UNSPECIFIED ION MODE | Creatine | 0.41 | peak area | Alzheimer’s disease model | B. breve MCC1274 |
| Normal phase UNSPECIFIED ION MODE | Creatine | 0.51 | peak area | Alzheimer’s disease model | Saline |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|